TFA Therapeutics, Inc. (RAJAF): Total Liabilities

Annual figures by period end, from SEC filings.

$5.19M
As of 2025-12-31
+19.3%
3-year compound annual growth
+12.8%
5-year compound annual growth
2020-12-31: $2.84M2021-12-31: $3.54M2022-12-31: $3.06M2023-12-31: $3.50M2024-12-31: $5.00M2025-12-31: $5.19M$5.19M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$5.19M+3.9%2026-05-15, Balance as of period end
2024-12-31$5.00M+42.7%2026-05-15, Balance as of period end
2023-12-31$3.50M+14.6%2025-09-23, Balance as of period end
2022-12-31$3.06M-13.6%2025-09-23, Balance as of period end
2021-12-31$3.54M+24.7%2023-05-15, Balance as of period end
2020-12-31$2.84Mn/a2023-05-15, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
TFA Therapeutics, Inc. (RAJAF)2025-12-31$5.19M+3.9%
Adia Med, Inc. (ADIA)2025-12-31$852.5K+33.1%
Target Group Inc. (CBDY)2025-12-31$14.24M+1.1%
Healthy Extracts Inc. (HYEX)2025-12-31$3.80M+92.9%
China Foods Holdings Ltd. (CFOO)2025-12-31$1.49M+15.9%
Nutra Pharma Corp (NPHC)2025-12-31$17.41M+13.0%
Functional Brands Inc. (MEHA)2025-12-31$7.57M+3.8%
Bon Natural Life Ltd (BON)2025-09-30$27.19M+56.1%
Charlie's Holdings, Inc. (CHUC)2025-12-31$8.14M+42.2%

Compare RAJAF, ADIA, CBDY, HYEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗